#AANAM – PND Stage May Not Be Reliable Measure of Neuropathy Progression

#AANAM – PND Stage May Not Be Reliable Measure of Neuropathy Progression

293121

#AANAM – PND Stage May Not Be Reliable Measure of Neuropathy Progression

Editor’s note: The FAP News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. A determined stage of polyneuropathy disability (PND) might not be a reliable indicator of neuropathy progression among people with familial amyloid polyneuropathy (FAP), an analysis of clinical trial data suggests. Findings from this analysis were presented in the poster, “Increase in Polyneuropathy Disability Stage Does Not Predict…

You must be logged in to read/download the full post.